Stay updated on Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe History page now shows Revision: v3.7.0, replacing the prior v3.6.6. This indicates a metadata or template update to how the record history is displayed, not a change to the study data.SummaryDifference0.1%

- Check19 days agoChange DetectedA new version adds major sections to the record, including Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Study Description, and Study Status, expanding the publicly visible content of the trial history. Additionally, the entry dated 2026-08-18 was removed.SummaryDifference0.5%

- Check33 days agoChange DetectedThe page history now shows Revision: v3.6.6 added, indicating an update to the record's revision version (replacing v3.6.5). This reflects an administrative change to the record's history rather than any change to study data or content.SummaryDifference0.1%

- Check40 days agoChange DetectedA new history entry on 2026-07-24 adds a Terminated status with a Business Reason and updates Study/Recruitment Status. The prior Completed entry from 2025-10-15 is removed.SummaryDifference0.4%

- Check54 days agoChange DetectedThe history shows the record updated to revision v3.6.5, replacing the previous v3.6.4. This indicates a new version of the page was published.SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision entry labeled v3.6.4 was added to the history, updating the page's version label. This is a metadata change and does not modify core trial information or user-facing content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.